WATSON 461 (Glipizide 10 mg)

Pill imprint WATSON 461 has been identified as Glipizide 10 mg.

Glipizide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 10 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for WATSON 461

Glipizide 10 mg WATSON 461
Glipizide 10 mg WATSON 461  Front
Glipizide 10 mg WATSON 461  Back
Glipizide 10 mg WATSON 461
Glipizide 10 mg WATSON 461
Glipizide
Imprint:
WATSON 461
Strength:
10 mg
Color:
White
Size:
10.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Sulfonylureas
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Watson Laboratories, Inc.
National Drug Code (NDC):
00591-0461
Inactive Ingredients:
silicon dioxide
croscarmellose sodium
lactose anhydrous
microcrystalline cellulose
corn starch
stearic acid
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
63739-0117 McKesson Packaging Services
54569-3842 A S Medication Solutions LLC (repackager)
67544-0129 Prepak Systems Inc (repackager)
16590-0287 Stat RX USA LLC (repackager)
68258-1013 Dispensing Solutions Inc. (repackager)
66336-0662 Dispensing Solutions Inc. (repackager)
58016-0376 Southwood Pharmaceuticals Inc (repackager)
63874-0432 Altura Pharmaceuticals Inc (repackager)
54868-3319 Physicians Total Care Inc (repackager)
21695-0470 Rebel Distributors Corp (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)